Our study results forecast a dramatic rise in the burden from dementia in the United States over the coming decades,” said ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

The researchers suggest that their estimates are higher because they took extra measures to avoid underestimating the number ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

People in the United States are living longer and with that comes increased rates of dementia. Dr. Josef Coresh, with NYU ...

A new study shows that the risk of developing dementia anytime after age 55 among Americans is 42%, more than double the risk reported by older studies.

Leading psychiatric educators are asking important questions about the best ways to train psychiatrists to address the needs ...

During the winter months, it is crucial to be extra mindful of loved ones with Alzheimer's and dementia. According to the ...

ProMIS Neurosciences (PMN) announced that its CEO Neil Warma, issued a letter to the company’s shareholders, the company said, “In my first ...

Tardive dyskinesia is a drug-induced neurological disorder characterized by involuntary movements of the face and body. The ...

Groundbreaking research reveals potential link between cytomegalovirus (CMV) and Alzheimer's disease, offering new insights ...

Tokyo, Japan and Cambridge, UK, 14 January 2025 - Nxera Pharma Co., Ltd. ("Nxera” or "the Company”; TSE 4565) is pleased to ...